Portola Pharmaceuticals, Inc. Discovering and developing novel therapeutics.
कंपनी विवरण:
portola pharmaceuticals is a biopharmaceutical company developing innovative drugs for the treatment of cardiovascular and inflammatory diseases portolaõs two most advanced programs are in phase ii clinical trials: 1) betrixaban, an oral, once-daily factor xa inhibitor being developed for stroke prevention in patients with atrial fibrillation (spaf) and for prevention of venous thromboembolism (vte) in various patient populations, and 2) elinogrel, a direct-acting, reversible oral and i.v. adp receptor antagonist initially being developed for patients with acute coronary syndrome (acs).
सर्च कीवर्ड:
biopharmaceutical company, innovative drugs, treatment of cardiovascular diseases, inflammatory diseases, betrixaban, factor xa inhibitor, stroke prevention, atrial fibrillation, prevention of venous thromboembolism, elinogrel, oral and i.v. adp receptor antagonist, acute coronary syndrome, antithrombotic, thrombosis, inflammatory diseases
कंपनी पता:
4941 Page Ave,MICHIGAN CENTER,MI,USA
ज़िप कोड : पिन कोड:
49254-1156
टेलीफोन नंबर :
5177640973 (+1-517-764-0973)
फैक्स नंबर :
5177645554 (+1-517-764-5554)
वेबसाइट:
www. portola. com
ईमेल:
संयुक्त राज्य अमेरिका इस प्रकार से कोड ( मानक औद्योगिक वर्गीकरण कोड) :